Bella Protocol vs Injective — how do they compare? Bella Protocol trades at Rp1,884 (market cap Rp151,49M, Rp100,45M 24h volume), while Injective trades at Rp86,066 (market cap Rp8,62T, Rp1,31T 24h volume). The key difference: Injective is far larger — about 56901.4× Bella Protocol's market cap, and Bella Protocol's circulating supply is 80M BEL versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Bella Protocol for 36 Days and Injective for 36 Days on average.
| BEL | INJ | |
|---|---|---|
Market Cap | Rp151,49M | Rp8,62T |
Volume (24h) | Rp100,45M | Rp1,31T |
Circulating Supply | 80M BEL | 100M INJ |
Typical Hold Time | 36 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Bella Protocol (BEL) is trading at Rp 1,888 with a market cap of Rp 150.96 million, showing a bullish technical signal supported by moving averages while oscillators remain neutral. The asset is positioned above key support levels with strong ADX readings indicating a solid trend. Recent on-chain activity shows a hold time of 36 days, suggesting moderate holder confidence. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.
Overall outlook is cautiously optimistic due to bullish technicals, but limited by neutral sentiment and low market cap volatility risks. Key opportunities include potential breakout above resistance; major risks involve low liquidity and absence of recent fundamental catalysts. Investors should monitor volume spikes and any new ecosystem announcements closely.
Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.
Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Bella Protocol is a platform that provides a suite of DeFi products designed to make crypto banking simpler and more accessible. The protocol aims to create a better user experience by eliminating the high fee and slow transaction issues that can affect some blockchain platforms while simultaneously improving the user experience through its simplified DeFi smart portal.
Read more on BEL →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →